Jubilant ingrevia
#jubilantingrea
Equirus initiates with target of 1,013rs
Expects the specialty chem to drive the growth
Lowest cost producer of pyridine derivatives with 20-80% mkt share
Nutrition n health science to grow steadily
Big volume growth expctd
Capex beneficiary
More from Shreenidhi P
Cosmo films
Investor ppt
Splty side:3yr target
Masterbatches-10% rev,20% RoCE
Textile chem-10% rev,25% RoCE
FMCG-Fabricizer launched
30% RoE,22% RoCE-fy21
1% shift in splty adds 5cr EBITDA
Target-62% to 80%
Net d/e 0.5x
D/EBITDA 1x
Petcare-plans 2 demerge in2 seperate entity https://t.co/Iq4VT6tG50
Investor ppt
Splty side:3yr target
Masterbatches-10% rev,20% RoCE
Textile chem-10% rev,25% RoCE
FMCG-Fabricizer launched
30% RoE,22% RoCE-fy21
1% shift in splty adds 5cr EBITDA
Target-62% to 80%
Net d/e 0.5x
D/EBITDA 1x
Petcare-plans 2 demerge in2 seperate entity https://t.co/Iq4VT6tG50
Cosmo films#cosmofilms
— Shreenidhi P (@nid_rockz) August 4, 2021
Probably the best results of the day
Glimpse of last 5qtr
Rev,EBITDA,pbt n PAT growth every qtr
Highest OPM 19%
Q1 EBITDA 132cr n PBT 116cr
Last 5yrs
OPM 7% to 17%\U0001f44c
80% pf-speciality-fy23
Superb debt management
Liberal dividend n buyback
Solid OCF\U0001f44c pic.twitter.com/6ulhmHZf24
First interview of Hiral Chandrana
#MASTEK
Adding 40+ customers every quarter from an year
650+ active clients
Met 150+ customers/partners virtually in last 40days
Focus to accelerate US growth-have strategy in place
960cr cash on books
Looking for organic+inorganic growth
#MASTEK
Adding 40+ customers every quarter from an year
650+ active clients
Met 150+ customers/partners virtually in last 40days
Focus to accelerate US growth-have strategy in place
960cr cash on books
Looking for organic+inorganic growth
#CNBCTV18Exclusive | Catch @_anujsinghal, @_soniashenoy & @SurabhiUpadhyay in conversation with @HiralChandrana who was appointed as global CEO of #Mastek last month. He says that a big part of their strategy is to grow in the US. @Reematendulkar pic.twitter.com/nRnfGoGHTp
— CNBC-TV18 (@CNBCTV18News) August 18, 2021
You May Also Like
@franciscodeasis https://t.co/OuQaBRFPu7
Unfortunately the "This work includes the identification of viral sequences in bat samples, and has resulted in the isolation of three bat SARS-related coronaviruses that are now used as reagents to test therapeutics and vaccines." were BEFORE the
chimeric infectious clone grants were there.https://t.co/DAArwFkz6v is in 2017, Rs4231.
https://t.co/UgXygDjYbW is in 2016, RsSHC014 and RsWIV16.
https://t.co/krO69CsJ94 is in 2013, RsWIV1. notice that this is before the beginning of the project
starting in 2016. Also remember that they told about only 3 isolates/live viruses. RsSHC014 is a live infectious clone that is just as alive as those other "Isolates".
P.D. somehow is able to use funds that he have yet recieved yet, and send results and sequences from late 2019 back in time into 2015,2013 and 2016!
https://t.co/4wC7k1Lh54 Ref 3: Why ALL your pangolin samples were PCR negative? to avoid deep sequencing and accidentally reveal Paguma Larvata and Oryctolagus Cuniculus?
Unfortunately the "This work includes the identification of viral sequences in bat samples, and has resulted in the isolation of three bat SARS-related coronaviruses that are now used as reagents to test therapeutics and vaccines." were BEFORE the
chimeric infectious clone grants were there.https://t.co/DAArwFkz6v is in 2017, Rs4231.
https://t.co/UgXygDjYbW is in 2016, RsSHC014 and RsWIV16.
https://t.co/krO69CsJ94 is in 2013, RsWIV1. notice that this is before the beginning of the project
starting in 2016. Also remember that they told about only 3 isolates/live viruses. RsSHC014 is a live infectious clone that is just as alive as those other "Isolates".
P.D. somehow is able to use funds that he have yet recieved yet, and send results and sequences from late 2019 back in time into 2015,2013 and 2016!
https://t.co/4wC7k1Lh54 Ref 3: Why ALL your pangolin samples were PCR negative? to avoid deep sequencing and accidentally reveal Paguma Larvata and Oryctolagus Cuniculus?